Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Review article: Pharmacologic management of obesity ‐ updates on approved medications, indications and risks
Camille Lupiañez-Merly, Saam Dilmaghani, Kia Vosoughi, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 4, pp. 475-491
Closed Access | Times Cited: 18

Showing 18 citing articles:

Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions
Ryan J. Jalleh, Christopher K. Rayner, Trygve Hausken, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 10, pp. 957-964
Closed Access | Times Cited: 18
Peptides Are Cardioprotective Drugs of the Future: The Receptor and Signaling Mechanisms of the Cardioprotective Effect of Glucagon-like Peptide-1 Receptor Agonists
Alla A. Boshchenko, Л. Н. Маслов, А. V. Mukhomedzyanov, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4900-4900
Open Access | Times Cited: 9
Digesting the complex metabolic effects of diet on the host and microbiome
Rachel N. Carmody, Krista A Varady, Peter J. Turnbaugh
Cell (2024) Vol. 187, Iss. 15, pp. 3857-3876
Closed Access | Times Cited: 9
Efficacy and safety of tirzepatide versus placebo in overweight or obese adults without diabetes: a systematic review and meta-analysis of randomized controlled trials
Ligang Liu, Hekai Shi, Merilyn Xie, et al.
International Journal of Clinical Pharmacy (2024) Vol. 46, Iss. 6, pp. 1268-1280
Open Access | Times Cited: 6
Pharmacological Treatment of Binge Eating Disorder and Frequent Comorbid Diseases
Hubertus Himmerich, Jessica Bentley, Susan L. McElroy
CNS Drugs (2024) Vol. 38, Iss. 9, pp. 697-718
Closed Access | Times Cited: 5
Mining and disproportionality analysis of adverse events signals for naltrexone based on real-world data from the FAERS database
Yaqi Zeng, Zhe Chen, Y. Luo, et al.
Expert Opinion on Drug Safety (2025)
Closed Access
Arthrocolin B Impairs Adipogenesis via Delaying Cell Cycle Progression During the Mitotic Clonal Expansion Period
Guang Cao, Xuemei Liao, Shuang Zhao, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1474-1474
Open Access
Dietary intake by patients taking GLP-1 and dual GIP/GLP-1 receptor agonists: A narrative review and discussion of research needs
Sandra M. Christensen, Katie N. Robinson, Sara Thomas, et al.
Obesity Pillars (2024) Vol. 11, pp. 100121-100121
Open Access | Times Cited: 3
Efficacy and safety of tirzepatide in overweight or obese adults without diabetes: systematic review and meta-analysis of randomized controlled trials
Ligang Liu, Milap C. Nahata, Hekai Shi, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 2
Evaluating the Impact of Novel Incretin Therapies on Cardiovascular Outcomes in Type 2 Diabetes: An Early Systematic Review
Teodor Salmen, Claudia-Gabriela Potcovaru, Cristina Bică, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1322-1322
Open Access | Times Cited: 1
Advances in Drug Treatments for Companion Animal Obesity
Helena D. Zomer, Paul S. Cooke
Biology (2024) Vol. 13, Iss. 5, pp. 335-335
Open Access | Times Cited: 1
Development of Novel N-Acylhydrazone Derivatives with High Anti-obesity Activity and Improved Safety by Exploring the Pharmaceutical Properties of Aldehyde Group
Zhi Jiang, Yu‐Tao Hu, Shi‐Yao Guo, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 14, pp. 12439-12458
Closed Access | Times Cited: 1
An integrated investigation combining network pharmacology and computer simulation dissects the potential mechanism of anti-obesity of Monascus pigments (MPs)
Jiaxing Li, Huijing Zhang, Linlin Xu, et al.
Food Bioscience (2024) Vol. 60, pp. 104459-104459
Closed Access
Mechanisms of neurodevelopmental toxicity of topiramate
John Steele, Vaishnav Krishnan, Richard H. Finnell
Critical Reviews in Toxicology (2024) Vol. 54, Iss. 7, pp. 465-475
Closed Access
Design, Synthesis and Structure-Activity Relationship of Novel 2-Pyrimidinylindole Derivatives as Orally Available Anti-Obesity Agents
Liyuan Wei, Yu-Wei Lin, Jia-Chun Luo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116773-116773
Closed Access
The weight reduction mediated by anti-obesity medication and the cardiovascular outcome
Yuchen Guo, Lin Chu, Xiaoling Cai, et al.
iScience (2024) Vol. 27, Iss. 10, pp. 110867-110867
Open Access
Anti-obesity and other health benefits of bioprocessed black rice bran in combination with green tea extract in 3T3-L1 preadipocyte cells and in mice on a high-fat diet
Ki Sun Kwon, Eunseok Lee, Kyung Hee Lee, et al.
Food & Function (2024)
Closed Access
Sygyzium claviflorum fruit extract preadipocyte differentiation inhibition in 3T3-L1 cells
Rozaini Mohd Zohdi, Muhammad Amirul Adli, Shahida Muhamad Mukhtar, et al.
Journal of Taibah University Medical Sciences (2024) Vol. 19, Iss. 6, pp. 1181-1192
Open Access
Page 1

Scroll to top